{"id":"W3027025576","doi":"10.1016/j.jval.2020.04.958","title":"PND66 RECENT EVOLUTION OF THE MARKET FOR DISEASE-MODIFYING DRUGS FOR MULTIPLE SCLEROSIS IN CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Teriflunomide; Fingolimod; Glatiramer acetate; Medical prescription; Dimethyl fumarate; Medicine; Multiple sclerosis; Ocrelizumab; Pediatrics; Family medicine; Internal medicine; Pharmacology; Psychiatry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002666257,0.0002791947,0.0003937615,0.001741241,0.001808655,0.003690413,0.0009868169,0.001684115,0.01687003],"category_scores_gemma":[0.007212891,0.0002625233,0.0007786241,0.001818234,0.001610936,0.0006641864,0.001029815,0.002392109,0.001217234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06435484,"about_ca_system_score_gemma":0.09876335,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9241122,"about_ca_topic_score_gemma":0.9380702,"domain_scores_codex":[0.9969245,0.0001782929,0.00009414308,0.0002537746,0.001921221,0.000628152],"domain_scores_gemma":[0.9908938,0.0006186664,0.0004537903,0.0000925339,0.00538867,0.002552433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.002929789,0.000481847,0.0476763,0.001319784,0.0002177533,0.002934892,0.00110269,0.004933682,0.02131157,0.09054983,0.3190629,0.5074789],"study_design_scores_gemma":[0.0002283511,0.0002301317,0.06366298,0.0003752431,0.00005982125,0.0005929142,0.0005530267,0.001609103,0.002885038,0.001566524,0.9281784,0.00005843438],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.2414404,0.06243101,0.009434863,0.244738,0.008022796,0.000719441,0.01492657,0.001031985,0.4172549],"genre_scores_gemma":[0.708761,0.03082336,0.009675342,0.04108163,0.00150713,0.0001171486,0.00556645,0.0003747739,0.2020931],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0758878,"threshold_uncertainty_score":0.4669293,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1012791563851129,"score_gpt":0.2873647926583867,"score_spread":0.1860856362732737,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}